133 related articles for article (PubMed ID: 20664943)
1. Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines.
Chen W; Leiter A; Yin D; Meiring M; Louw VJ; Koeffler HP
Int J Oncol; 2010 Sep; 37(3):737-43. PubMed ID: 20664943
[TBL] [Abstract][Full Text] [Related]
2. Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme.
Yin D; Wakimoto N; Xing H; Lu D; Huynh T; Wang X; Black KL; Koeffler HP
Int J Cancer; 2008 Sep; 123(6):1364-75. PubMed ID: 18561312
[TBL] [Abstract][Full Text] [Related]
3. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
Liu T; Peng H; Zhang M; Deng Y; Wu Z
Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353
[TBL] [Abstract][Full Text] [Related]
4. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.
Yar Saglam AS; Alp E; Elmazoglu Z; Menevse S
Hum Exp Toxicol; 2016 May; 35(5):526-43. PubMed ID: 26183715
[TBL] [Abstract][Full Text] [Related]
5. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
[TBL] [Abstract][Full Text] [Related]
6. Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft.
Hsu CY; Yanagi T; Maeda T; Nishihara H; Miyamoto K; Kitamura S; Tokuchi K; Ujiie H
Sci Rep; 2023 May; 13(1):8650. PubMed ID: 37244956
[TBL] [Abstract][Full Text] [Related]
7. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer.
Shin DM; Glisson BS; Khuri FR; Clifford JL; Clayman G; Benner SE; Forastiere AA; Ginsberg L; Liu D; Lee JJ; Myers J; Goepfert H; Lotan R; Hong WK; Lippman SM
J Clin Oncol; 2002 Jan; 20(2):364-70. PubMed ID: 11786562
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin B induces inhibitory effects via CIP2A/PP2A/Akt pathway in glioblastoma multiforme.
Qin S; Li J; Si Y; He Z; Zhang T; Wang D; Liu X; Guo Y; Zhang L; Li S; Li Q; Liu Y
Mol Carcinog; 2018 Jun; 57(6):687-699. PubMed ID: 29393542
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin B and cisplatin induce the cell death pathways in MB49 mouse bladder cancer model.
Kurman Y; Kiliccioglu I; Dikmen AU; Esendagli G; Bilen CY; Sozen S; Konac E
Exp Biol Med (Maywood); 2020 May; 245(9):805-814. PubMed ID: 32252554
[TBL] [Abstract][Full Text] [Related]
10. Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.
Chan LP; Chou TH; Ding HY; Chen PR; Chiang FY; Kuo PL; Liang CH
Biochim Biophys Acta; 2012 Jul; 1820(7):1081-91. PubMed ID: 22554915
[TBL] [Abstract][Full Text] [Related]
11. NR5A2 promotes malignancy progression and mediates the effect of cisplatin in cutaneous squamous cell carcinoma.
Ye W; Ya-Xuan C; Shan-Shan T; Qiu L; Ting M; Shao-Jie C; Yu C
Immun Inflamm Dis; 2024 Feb; 12(2):e1172. PubMed ID: 38358044
[TBL] [Abstract][Full Text] [Related]
12. GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth.
Ding LT; Zhao P; Yang ML; Lv GZ; Zhao TL
Biochem Biophys Res Commun; 2018 Sep; 503(3):1941-1948. PubMed ID: 30072096
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma.
Liu T; Zhang M; Zhang H; Sun C; Deng Y
Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1225-32. PubMed ID: 18309509
[TBL] [Abstract][Full Text] [Related]
14. Cucurbitacin B exerts anti-cancer activities in human multiple myeloma cells in vitro and in vivo by modulating multiple cellular pathways.
Yang T; Liu J; Yang M; Huang N; Zhong Y; Zeng T; Wei R; Wu Z; Xiao C; Cao X; Li M; Li L; Han B; Yu X; Li H; Zou Q
Oncotarget; 2017 Jan; 8(4):5800-5813. PubMed ID: 27418139
[TBL] [Abstract][Full Text] [Related]
15. The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas.
Tian XP; Qian D; He LR; Huang H; Mai SJ; Li CP; Huang XX; Cai MY; Liao YJ; Kung HF; Zeng YX; Xie D
Cancer Lett; 2014 Oct; 353(1):104-14. PubMed ID: 25045845
[TBL] [Abstract][Full Text] [Related]
16. The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer.
Aribi A; Gery S; Lee DH; Thoennissen NH; Thoennissen GB; Alvarez R; Ho Q; Lee K; Doan NB; Chan KT; Toh M; Said JW; Koeffler HP
Int J Cancer; 2013 Jun; 132(12):2730-7. PubMed ID: 23165325
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the effectiveness of cisplatin and 5-fluorouracil on cutaneous squamous human carcinoma cell line: Potential chemotherapy alternative to surgery.
Gil S; Yébenes M; Luelmo J; Alsina M; Sabés M
Dermatol Ther; 2016 Sep; 29(5):341-344. PubMed ID: 27292650
[TBL] [Abstract][Full Text] [Related]
18. MiR-3619-5p hampers proliferation and cisplatin resistance in cutaneous squamous-cell carcinoma via KPNA4.
Zhang M; Luo H; Hui L
Biochem Biophys Res Commun; 2019 May; 513(2):419-425. PubMed ID: 30967266
[TBL] [Abstract][Full Text] [Related]
19. Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activity.
Xu J; Chen Y; Yang R; Zhou T; Ke W; Si Y; Yang S; Zhang T; Liu X; Zhang L; Xiang K; Guo Y; Liu Y
Arch Biochem Biophys; 2020 May; 684():108314. PubMed ID: 32088220
[TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin B induces apoptosis of primary effusion lymphoma via disruption of cytoskeletal organization.
Ueno M; Kariya R; Sittithumcharee G; Okada S
Phytomedicine; 2021 May; 85():153545. PubMed ID: 33799222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
